Hepatitis E

Study of AT-587 in Healthy Subjects

Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies

Seroprevalence of Hepatitis E in People With an Organ Transplant

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above

Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors

Exposure to Hepatitis E Virus in Occitania, France

Long-term Effectiveness of a Recombinant Hepatitis E Vaccine

Safety Study of Hepatitis E Vaccine (HEV239)

Morbidity and Mortality of Hepatitis E Virus Infections in Belgium

Clinical Trial of Recombinant Hepatitis E Vaccine

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver